CAS: 383715-23-9

N-(3-Methoxybenzyl)(9Z,12Z,15Z)-octadeca-9,12,15-trienamide is a synthetic chemical compound that functions as an inhibitor of fatty acid amide hydrolase (FAAH). FAAH is an enzyme responsible for the breakdown of fatty acid amides, including endocannabinoids. The compound is derived from natural sources, specifically designed to mimic the structures found in biological systems, enhancing its compatibility and efficiency in biological assays. The mode of action of N-(3-Methoxybenzyl)(9Z,12Z,15Z)-octadeca-9,12,15-trienamide involves the selective inhibition of FAAH, leading to elevated levels of fatty acid amides such as anandamide. This results in modulated signaling pathways associated with the endocannabinoid system. The alteration in these pathways holds significance for investigating physiological processes such as pain, mood regulation, and inflammation. In research, N-(3-Methoxybenzyl)(9Z,12Z,15Z)-octadeca-9,12,15-trienamide is utilized to explore novel therapeutic avenues targeting conditions related to the endocannabinoid system dysregulation. It serves as a crucial tool in understanding enzyme-substrate interactions and potential pharmacological interventions.

N-(3-Methoxybenzyl)(9Z,12Z,15Z)-octadeca-9,12,15-trienamide is a natural product